\
&
Contact us
\
&
Contact us
Published on | 5 years ago
Programmes SwafSThis European Commission document reports on the Horizon 2020 Science with and for Society (SwafS) science education project portfolio results. The objective of this report is to convey the achievements of the science education projects funded under the SwafS part of Horizon 2020. Its purpose is to serve as input for the preparation of the Horizon Europe programme implementation. It suggests to foresee standalone topics on Science Education, foresee mainstreaming of science education in other parts of the programme, seek links beyond Horizon Europe and explore synergies with similar funding schemes in Europe.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
